Date: 2017-01-17
Type of information: Nomination
Compound:
Company: Bavarian Nordic (Denmark)
Therapeutic area: Cancer - Oncology - Infectious diseases
Type agreement: nomination
Action mechanism:
Disease:
Details: * On January 17, 2017, Bavarian Nordic announced the appointment of Henrik Birk as Chief Operating Officer. In this newly created position, Mr. Birk will develop and lead the execution of Bavarian Nordic's operational and HR strategies. Mr. Birk will become a member of executive management, reporting directly to Paul Chaplin, Chief Executive Officer. Prior to joining Bavarian Nordic in 2008, Mr. Birk served in various management positions at Coloplast focusing on supply chain and production. Since joining Bavarian Nordic, he has served in positions of increasing responsibility, most recently as Senior Vice President, Strategy, People and Organization. Mr. Birk holds a Masters of Business Administration from Henley Business School. The executive management of Bavarian Nordic is now comprised of Paul Chaplin, President and CEO, Ole Larsen, Executive Vice President and CFO, and Henrik Birk, Executive Vice President and COO.
Financial terms:
Latest news:
